Metabolomics-guided isolation of anti-trypanosomal metabolites from the endophytic fungus Lasiodiplodia theobromae by Kamal, Nurkhalida et al.
Kamal, Nurkhalida and Viegelmann, Christina V. and Clements, Carol J. 
and Edrada-Ebel, RuAngelie (2016) Metabolomics-guided isolation of 
anti-trypanosomal metabolites from the endophytic fungus 
Lasiodiplodia theobromae. Planta Medica. ISSN 0032-0943 , 
http://dx.doi.org/10.1055/s-0042-118601
This version is available at https://strathprints.strath.ac.uk/59826/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any correspondence concerning this service should be sent to the Strathprints administrator: 
strathprints@strath.ac.uk
The Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research 
outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the 
management and persistent access to Strathclyde's intellectual output.
1 
Metabolomics-guided isolation of anti-trypanosomal metabolites from the 
endophytic fungus Lasiodiplodia theobromae  
 
 
Nurkhalida Kamal1, 2, Christina V. Viegelmann1, Carol J. Clements1, RuAngelie 
Edrada-Ebel1 
 
 
Affiliation 
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 
The John Arbuthnott Building, 161 Cathedral Street, Glasgow G4 0RE, United 
Kingdom  
2Faculty of Pharmacy, Cyberjaya University College of Medical Sciences (CUCMS), 
Cyberjaya, 63000, Selangor, Malaysia 
 
 
Correspondence Authors: 
RuAngelie Edrada-Ebel,  
Email: ruangelie.edrada-ebel@strath.ac.uk 
Telephone: +44-(0)-141-548-5968 Fax: +44-(0)-141-552-2562 
Nurkhalida Kamal 
Email: minnur_27@yahoo.com Telephone: +44-(0)-141-548-3728 
2 
Abstract 
 
Fungal endophytes offer diverse and unique secondary metabolites, making 
these organisms potential sources of promising drug leads. The application of High 
Resolution-Liquid Chromatography Mass Spectrometry (HR-LCMS) and Nuclear 
Magnetic Resonance (NMR) -based metabolomics to fungal endophytes is practical in 
terms of dereplication studies and the mining of bioactive compounds. In this paper we 
report the application of metabolomics in parallel with anti-trypanosomal assays to 
determine the ideal conditions for the medium-scale fermentation of the endophyte 
Lasiodiplodia theobromae. The 1H NMR comparison between the active versus inactive 
fractions identified several unique chemical fingerprints belonging to the active 
fractions.  Furthermore, by integrating HR-LCMS data with chemometric data analysis, 
such as partial least squares-discriminant analysis (PLS-DA), orthogonal PLS-DA 
(OPLS-DA), and S-plots and the bioactivity results of the fractions of L. theobromae, 
the most predictive anti-trypanosomal agents were easily discerned. With available 
databases such as Antibase and MarinLit coupled to MZmine by in-house algorithms 
optimized in our laboratory, the predictive metabolites were readily identified prior 
isolation. Fractionation was performed on one of the active fractions and three known 
compounds were isolated, namely cladospirone B, desmethyl-lasiodiplodin, and R-(-) 
mellein. Cladospirone B and desmethyl-lasiodiplodin were among the predictive 
compounds generated by the S-plot, and these compounds exhibited good activity 
against Trypanosoma brucei brucei with MICs of 17.8 µM and 22.5 µM, respectively. 
Therefore, HR-LCMS and NMR-based metabolomics proved to be a powerful decision-
making tool in mining active metabolites of L. theobromae against T. b. brucei. 
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Introduction 
 
Despite the increasing disinclination of the pharmaceutical industry to pursue natural 
products in their pipelines, statistical findings show that natural products still play a 
major role in drug discovery with more than 50% of FDA-approved drugs derived from 
natural products/mimics [1]. However, natural products research has been found to be 
too laborious, time-consuming and uneconomical, which may have led to the declining 
trend. Nevertheless, with the emergence of new and more advanced technologies such 
as genomics, transcriptomics, proteomics, metabolomics and bioinformatics, natural 
products research has become more competent in finding promising novel drugs for the 
pipeline [1-4]. 
 
The utilization of metabolomics in natural products research is increasingly powerful in 
several perspectives. Metabolomics is defined as a global study of all or a subset of 
chemical entities including either or both primary and secondary metabolites, that are 
present in living organisms (cells or tissues) under certain growth conditions [5-7]. 
Metabolomics, or metabolome mining, in natural products research has been used for 
dereplication studies of both known and new compounds in crude plant, marine or 
microbial extracts [8-18], in differentiating biologically active natural products (NPs) 
from non-active fractions [19-23], optimising the production of bioactive secondary 
metabolites, as well as in developing cultivation processes for large-scale fermentation 
and understanding their biosynthetic pathways [7,24].  
 
Endophytic fungi are microorganisms that mutually live inside plant tissues without 
causing any immediate negative effects towards the host plant for at least a part of 
5 
fungal life cycle [25]. The total population of endophytic fungi species has been 
estimated to be up to 1.3 million [26]. Another study places this estimate at 
approximately 1.5 million [27]. However, as of the year 2000, only 75 000 fungal 
species have been identified; the remainder are still untapped and unexplored [28]. 
Bioactive NPs derived from endophytic fungi display wide ranges of activities, such as 
(±)-oxysporidinone, (2,6-dihydroxyphenyl)pentan-1-one and (Z)-1-(2-(2-butyryl-3-
hydroxyphenoxy)-6-hydroxyphenyl)-3-hydroxybut-2-en-1-one exhibited antimicrobial 
[29,30], pullularin A and hinnuliquinone displayed antiviral [31,32],  and 
spiropreussione A  and  9-deacetoxyfumigaclavine C for anticancer  activity [33,34]. 
Compounds like cochlioquinone A, isocochlioquinone A and cercosporin exhibited 
activity against  neglected tropical diseases [35,36].  
 
Human African trypanosomiasis or sleeping sickness is a fatal vector-borne parasitic 
disease caused by Trypanosoma b. brucei DQGWUDQVPLWWHGE\WKHWVHWVHÀ\Glossina 
spp.). This neglected tropical disease occurs only in rural areas of sub-Saharan Africa 
(Simarro, 2011). To date only a few drugs have been approved for the treatment of 
Human African trypanosomiasis. These include suramin, pentamidine, melarsoprol, 
eflornithine and the combination of nifurtomox/eflornithine. Most of the drugs are old, 
having been discovered in the 1940s and 1950s, and have adverse effects such as 
nausea, vomiting, fatigue, seizures, fever, diarrhea, hypoglycemia, abdominal cramping, 
peripheral neuropathy, hypertension, heart damage and neutropenia on the patients. For 
this reason, mining and developing new Human African trypanosomiasis drugs from 
natural products is crucial and essential because various natural sources including 
plants, microorganisms, animals, and marine organisms offer high number of NPs with 
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diverse chemical structures and novel pharmacological mechanism of action (Jacobs, 
2011).  
 
The aim of this study is to adopt an untargeted HR-LCMS (High Resolution-Liquid 
Chromatography Mass Spectrometry) and NMR-based metabolomics approach to 
determine the optimal conditions of Lasiodiplodia theobromae for medium-scale 
fermentation and also to capture and trace active anti-trypanosomal metabolites by 
using statistical multivariate data analysis of generated HR-LCMS data, such as 
Principal Component Analysis (PCA), Orthogonal Partial Least Squares-Discriminant 
and Analysis (OPLS-DA). To verify the dereplication results obtained from HR-LCMS 
data, 1D and 2D 1H NMR data were utilized. Finally, the isolation of active metabolites 
was performed based on the outcome of HR-LCMS and NMR-based metabolomics 
profile data. 
 
Results and discussion 
 
In search of the best condition for scaling up the culture of the endophyte L. theobro-
mae obtained from the leaves of V. pinnata, HR-LCMS and NMR-based metabolomics 
along with the bioassay data were utilized. The fungus was grown in solid rice cultures 
and liquid Wickerham cultures for seven, fifteen and thirty days, after which the metab-
olites were extracted. The three different incubation times were chosen based on the 
fungal life-cycle [39]. In this case, the first seven days represent the germination phase, 
while the fifteen-day and thirty-day cultures cover the hyphal growth stage and sporing 
phase, respectively, of L. theobromae. The production of secondary metabolites was 
monitored using HR-LCMS and NMR at each of the growth phases parallel to the bio-
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assay results. Based on the bioassay results (Table 1), the 30-days rice culture extract 
exhibited the strongest activity against T. b. brucei with an MIC of less than 25 ȝJPO
The HR-LCMS raw data was processed using MZMine 2.10 [40]. The results of the as-
say were reproducible between the scale-up batches. Metabolite production and distri-
bution between cultures were analyzed through ion peak scatter plots (Fig. 1). Based on 
the MS data, the occurrences of the metabolites on the 7th and 15th days were similar 
while a decrease in metabolite production was observed on the 30th day. In addition, 
the ion chromatogram both in positive and negative mode revealed a different set of 
metabolites on the 30th day to those of the 7th and 15th-day extracts (Fig. 1). Moreover, 
the 1H NMR data revealed findings similar to the MS data (Fig. 2). Therefore, the 30-
day rice culture condition was chosen for scale-up and further isolation work. 
 
Table 1  
 
Fig. 1  
 
Fig. 2 
 
The medium-scale 30-day rice culture extract of L. theobromae was fractionated yield-
ing 19 fractions (LT-1 until LT-19). These were submitted for the anti-trypanosomal 
activity and 1H NMR metabolomics. The non-polar fractions LT-2 to LT-8 exhibited 
strong bioactivity, except for LT-4 which showed only moderate activity against T. b. 
brucei (Fig. 3). LT-1 was excluded from the bioassay screening because it contained 
only fatty acids as indicated by its 1H NMR data (Fig. 4). The 1H NMR data of the 19 
fractions (Fig. 4) were analyzed, and unique chemical fingerprints of the active frac-
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tions were detected. Among these active fractions, two distinctive sub-groups, LT-2 to 
LT-4 and LT-6 to LT-8, clustered together as they shared similar spectral data. Fraction 
LT-5 was a mixture of both groups. The 1H NMR spectra of fractions LT-2 to LT-5 
displayed a pair of meta-coupled aromatic protons DWįH 6.23 and 6.28 (J= 2.7 Hz) and a 
PXOWLSOHWSHDNDWįH 5.15 which may be an olefinic or oxygenated methine. The upfield 
shift of the meta-coupled aromatic protons at the 6 ppm region suggested the presence 
of an electron-withdrawing group such as a hydroxyl or halogen substituent. In frac-
tions LT-5 to LT-8 two meta-FRXSOHGGRXEOHWVDWįH 6.18 and 6.25 (J=2.6 Hz) were ob-
served (see red arrow in Fig. 4). The proton signals between 4.2- 4.8 ppm revealed the 
presence of oxygenated methines while proton signals between 6.6 to 7.7 ppm indicated 
the presence of aromatic compounds in fractions LT 6 to LT8. 
 
Fig. 3  
 
Fig. 4  
Supervised methods of multivariate data analysis were used to analyze the similarity of 
the data sets between 19 samples. Principal component analysis (PCA) was used in ear-
lier step to observe an overview of variance between the fractions and metabolites gen-
erated from MS data and also to identify any outliers. The distribution difference of the 
type of metabolites between active vs inactive fractions of L. theobromae against T. b. 
brucei was analyzed by subjecting the data to OPLS-DA. The results of the analysis led 
to the prediction of compounds that contribute towards the anti-trypanosomal activity of 
the fractions. For the OPLS-DA models (Fig. 5a), the MS-based metabolomics data set 
was assigned as the X independent variaEOHZKLOHWKHIUDFWLRQV¶anti-trypanosomal re-
sponse was the Y dependent variable. The quality of OPLS-DA model was measured by 
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two parameters, R2 (goodness of fit), and Q2 (predictive ability) DQGWKHPRGHO¶V5X 
was 0.261, R2Y was 0.955 and Q2 was 0.733. These results were interpreted that 26.1% 
of the X variables could be used to describe 95.5% of the variation between active frac-
tions and inactive fractions while this model has 73.3% of the average of prediction 
ability.  The value of R2Y and Q2 was greater than 50%, indicating a well-fitted model 
exhibiting good prediction (Robotti, 2016).  The quality and robustness of OPLS-DA 
model was validated by a permutation test (n=100) with the Q2-intercept value was -
0.368 (below 0.05) shows that the original model is statistically effective (Fig. 5b) 
{Haoula, 2015 #1012}.  For the OPLS-DA scores plot (Fig. 5a), the active fractions 
were clustered together versus the inactive ones. Under the active group, fractions LT-2 
to LT-5 (Group 1) and LT-6 to LT-8 (Group 2) clustered together indicating a shared 
set of metabolites while fractions LT-9 to LT-19 were observed as outliers of the group.  
The generated S-plot (Fig. 5d) GHWHUPLQHGWKH³HQGSRLQW´or unique compounds for 
each of the respective groups, indicating the metabolites that are potentially responsible 
for the bioactivity against T. b. brucei which discriminated the active from the inactive 
fractions of L. theobromae.  Eight metabolites were identified from Antibase and 
MarinLit as shown in Table 2. The end point compounds were targeted for bioassay-
guided isolation work with three active compounds in Group 1 and the remaining five 
active compounds in Group 2. 
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Fig. 5  
 
Table 2  
 
Fig. 6  
 
In Group 1, the active metabolites listed from the dereplication step of the HR-LCMS 
data were identified as palmarumycin CP17 (5), cladospirone B (6) and desmethyl-
lasiodiplodin (8). Further analysis of the 1H-1H COSY NMR spectrum of fraction LT-3 
revealed substructures belonging to the predicted active metabolites. For example, the 
correlation of the meta-coupled aromatic protons DWįH 6.23 and 6.28, as well as that of 
the methyl doublet at įH 1.35 with one oxygenated methine proton DWįH 5.15 which fur-
ther correlated with the aliphatic chain were characteristics of the desmethyl-
lasiodiplodin structure (8) (see Fig. 7). Substructures of palmarumycin CP17 and 
cladospirone B were elucidated in the same manner. 
 
Fig. 7  
 
A similar approach was used for Group 2. Fraction LT-7 was selected based on the 
OPLS-DA data which indicated the bioactive metabolite. Among these metabolites, the 
structure of the compound 6-oxo-de-O-methyllasiodiplodin (2) was confirmed by its 
COSY spectral data, which exhibited correlations similar to desmethyl-lasiodiplodin 
(8), as shown in Figure 8a. In the aromatic region, the COSY spectrum revealed corre-
lations for preussomerin-C (Figure 8b). 
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Fig. 8  
Isolation and purification of the compounds in Group 1 was performed by high-
throughput MPLC. Three known compounds were isolated and elucidated based on 
their NMR and MS data as cladospirone B (6) [43], desmethyl-lasiodiplodin (8) [44], 
and R-(-)-mellein (9) [45]. The isolation of cladospirone B (6) and desmethyl-
lasiodiplodin (8) confirmed the putative identification of the metabolites in Group 1 
predicted earlier by the S-plot of the OPLS-DA model. R-(-)-mellein (9) is structurally 
close analogue of 6,8-dihydroxy-3-methylisocoumarin (1). All isolated compounds 
were tested against T. b. brucei, and cladospirone B (6) and desmethyl-lasiodiplodin (8) 
had MICs of 17.8 and 22.5 µM, respectively. All three metabolites were checked again 
in the S-plot and R-(-)-mellein was located in the middle of the plot suggesting that the 
anti-trypanosomal activity would be less (Fig. 9); this is indeed the case as confirmed 
by the bioassay results. Due to the limited amount of sample, however, palmarumycin 
CP17 was not isolated. Desmethyl-lasiodiplodin (8) has been known to exhibit anti-
cancer activity against MCF-7 via apoptosis with an IC50 seven-fold more potent than 
its toxicity on normal cells [46].  On the other hand, cladospirone B (6) has been report-
ed to be inactive in antibacterial and antifungal assays [45]. Further isolation and purifi-
cation of five other active metabolites from Group 2 is still on-going. 
 
Fig. 9  
 
Table 3  
 
In our screening program, we observed that the crude extract of L. theobromae from 
agar plates showed anti-trypanosomal activity against T. b. brucei. In order to find the 
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optimal conditions to grow L. theobromae, HR-LCMS-based metabolomics was 
applied, which resulted in the selection of solid rice culture for 30 days as the best 
conditions for medium-scale fermentation. Fractionation was performed on the crude 
extract, and based on the 1D 1H NMR data comparison of 19 fractions several unique 
chemical fingerprints in the active fractions were highlighted. Furthermore, by utilizing 
the HR-LCMS data for chemometric analysis such as OPLS-DA, an S-plot and 
consequently, a set of the metabolites that were predicted to be active was generated. 
All predictive metabolites were easily identified with the aid of databases such as 
AntiBase and MarinLit, which were coupled to MZmine by in-house algorithms. The 
application of 1H NMR and COSY allowed the detection of the predictive metabolites 
within the active fractions as well as the confirmation of the dereplication results 
obtained from the HR-LCMS data. Further isolation of secondary metabolites was 
performed on fraction LT-2 (active fraction in Group 1). Three known compounds were 
isolated and identified as cladospirone B (6), desmethyl-lasiodiplodin (8) and R-(-)-
mellein (9).  The isolation of cladospirone B (6) and desmethyl-lasiodiplodin (8) 
confirmed the putative identification of the metabolites in Group 1 predicted earlier by 
the S-plot of the OPLS-DA model. To our best knowledge, this is the first report of 
isolation of cladospirone B (6) from L .theobromae. It is also the first report to indicate 
the good anti-trypanosomal activity of cladospirone B (6) and desmethyl-lasiodiplodin 
(8) against T. b. brucei with MICs of 17.8 and 22.5 µM, in comparison with suramin 
(MIC value of ȝ0) respectively. Our strategy of emphasizing HR-LCMS and 
NMR-based metabolomics to search for active anti-trypanosomal compounds has 
therefore proven to be effective. In conclusion, this study determined that the 
combination of HR-LCMS and NMR-based metabolomics is a powerful and 
advantageous decision-making tool in mining active metabolites of L. theobromae 
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against T. b. brucei and is also promising for implementation in other drug discovery 
programs elsewhere. 
 
Materials and methods 
 
Fungal sampling  
The fungus L. theobromae was isolated from fresh healthy leaves of Vitex pinnata 
collected in April 2011 near Kuala Terengganu, Malaysia. The plant was identified by 
Dr. Nashriyah Mat from the Faculty of Bioresources and Food Industry, Universiti 
Sultan Zainal Abidin and voucher specimen was deposited (collection number VP 01).   
Samples were kept in zip lock bags and stored at 4°C until the isolation of endophytic 
fungi was performed four days later. The surfaces of the leaves and stems were 
sterilised with 70% iso-propanol for two minutes and subsequently rinsed in sterile 
water. Small tissue samples from inside the leaves and stems were cut aseptically and 
pressed onto agar plates (composition of isolation medium: 15 g/L malt extract, 15 g/L 
agar, and 0.2 g/L chloramphenicol in distilled water, pH 7.4-7.8, adjusted with 10% 
NaOH or 36.5% HCl). ChloramphenicolSXULW\ (Sigma Aldrich) was added to 
inhibit bacterial growth. The plates were left for a few days until fungal growth was 
observed. Reinoculation onto new malt agar plates was repeated several times until pure 
strains were attained. 
 
Identification of fungal strains  
The fungal strain was identified using DNA amplification and sequencing of the 
internal transcribed spacer (ITS) region as described previously [47]. The sequence data 
has been submitted to GenBank with accession number KC960898. The fungal strain 
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was identified as Lasiodiplodia theobromae. A voucher strain was submitted and kept 
at the Natural Product Metabolomics Laboratory, SIPBS.  
 
Small and medium-scale fermentation 
The fungal strain was cultivated on malt agar plates for seven days at 30°C.  The 
colonies and agar were cut into small pieces and were placed in liquid or solid media. 
The liquid medium used was Wickerham medium, consisting of 3 g yeast extract, 3 g 
malt extract, 5 g peptone, 10 g glucose, distilled water added up to 1000 mL in 2L 
Erlenmeyer flasks, pH 7.2-7.4, adjusted with 10% NaOH or 36.5% HCl. The solid 
medium used was rice medium, with 100 g of long grain rice and 100 mL of distilled 
water autoclaved together in 1L Erlenmeyer flasks. The strain was grown for three 
different incubation times: seven, fifteen and thirty days, under static conditions at room 
temperature. For medium-scale fermentation, L. theobromae was cultivated in 1L flasks 
using the optimal conditions as determined by the small-scale cultures. In this case, the 
growth of the fungus on rice medium for 30 days under static conditions was 
determined to be the most favorable condition for the production of anti-trypanosomal 
metabolites. 
 
Extraction and Isolation of Pure Compounds 
The medium-scale rice cultures were extracted with ethyl acetate and homogenized as 
finely as possible using a T18 Basic Ultra-Turrax (IKA) at maximum speed. These were 
then kept overnight. The extract was subsequently dried under vacuo using a rotary 
evaporator (Buchi Labortechnik AG). The crude extract (5.0 g) was then partitioned 
with 10% n-hexane and 90% methanol to remove fatty acids. The extract containing 
methanol-soluble compounds (2.0 g) was collected for further isolation work. The 
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fractionation of the methanol extract was accomplished using Medium Pressure Liquid 
Chromatography (MPLC). Linear gradient elution was employed with hexane (A) and 
ethyl acetate (B) as the mobile phase at a flow rate of 20 mL/min. A pre-packed silica 
column (20±45 ȝP[PP6LOLFD VersaPak cartridge) was used. It was 
connected to a Buchi Pump Manager C-615 coupled to binary pumps (Buchi Modules 
C-601). 100% A was run for 5 min, followed by 100% A to 100% B for 20 min, and 
finishing with 100% B for the last 5 min. The total run time was 30 min. Fractions were 
collected in collection tubes automatically every 2 mL using a fraction collector Frac 
920 (GE Healthcare Bio-Sciences AB). Fractions with similar TLC profiles were 
pooled together, yielding a total of nineteen fractions. Fraction LT-2 (435 mg) was 
further subjected to MPLC on a pre-packed silica column (20±ȝP[3 mm, 
Silica VersaPak cartridge) utilizing an isocratic gradient system (80% n-hexane : 20% 
ethyl acetate) for 30 min at a flow rate of 20 mL/min. In total, 300 collection tubes of 
fractions (2 mL in each tube) were collected automatically and using their TLC profiles. 
Similar fractions were pooled, resulting in 17 fractions and giving three known 
compounds 6 (3 mg), 8 (73 mg) and 9 (11 mg). 
 
In vitro anti-trypanosomal assay 
The samples were prepared to a final concentration of 10 mg/mL (stock solution) by 
being dissolved in the appropriate amount of DMSO. To screen for in-vitro activity, a 
concentration of 200 µg/mL was used. This was achieved by diluting the stock solution 
1 in 10 with HMI-9 (drug solution). 4 µL of drug solution was transferred to 96 µL of 
HMI-9 in the 96-well plate. 100 µL of trypanosome suspension, consisting of T. b. 
brucei S427 blood stream form at 3 x 104 trypanosomes/mL, were then added to the 96-
well plate WRPDNHWKHILQDOFRQFHQWUDWLRQRIWKHFRPSRXQGVUDQJHGIURPȝJP/WR
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ȝJP/ DMSO was used as the negative control (concentration of 1 to 0.002%) 
and suramin (Calbiochem-Novabiochem Co.) was selected as the positive control 
(concentration of 1 to 0.008 µM). The plate was incubated for 48 hours at 37මC, 5% 
CO2 with a humidified atmosphere, after which 20 µL of Alamar blue was added. The 
plate was again incubated for another 24 hours under the same conditions. The 
fluorescence was measured using a Wallac Victor microplate reader (PerkinElmer) with 
excitation at 530 nm and emission at 590 nm. The results were calculated as 
percentages of control values. All samples that exhibited > 90% inhibition were 
selected for the minimum inhibitory concentration (MIC) assay to determine the MIC 
value. 
 
NMR Instrumentation 
One-and two-dimensional 1H and 13C NMR spectra were recorded at 400 MHz on a 
JEOL-LA400 FT-NMR spectrometer system with a 40TH5AT/FG probe (JEOL LTD.). 
Compounds 6 and 8 were reconstituted in deuterated chloroform (CDCl3) while 
compound 9 was reconstituted in deuterated DMSO (DMSO-d6).  
 
HR-LCMS Procedure 
HR-LCMS was measured using an Accela 600 HPLC pump with Accela autosampler 
and UV/Vis detector (Thermo Scientific) and Orbitrap Exactive mass spectrometer 
(Thermo Fisher Scientific Inc). Analysis of samples was done using similar protocols 
described previously [23,47,48]. 
 
HR-LCMS data processing 
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Initially the raw HR-LCMS data were sliced into two data sets according to ionization 
mode using the MassConvert tool from ProteoWizard (ProteoWizard Homepage) 
(http://proteowizard.sourceforge.net/). The sliced data were imported to MZMine 2.10 
(http://sourceforge.net/projects/mzmine/), a software developed for the differential 
analysis of mass spectrometry data (Pluskal) The data processing step was performed in 
the same manner as explained by (Abdelmohsen, 2014) albeit with slightly modified 
parameters. In this analysis, the data set was crop-filtered from 0.1 to 35 min and the 
retention time normalizer was not applied because only one batch of data was used.  
 
Statistical Analysis 
MS spectral data were converted to an ASCII text file and imported to MS-Excel. The 
data was sorted to exclude background peaks that belonged to the MeOH blank. The 
sorted data were then exported to the SIMCA-P software 14.0 version (Umetrics). 
Pareto scaling was employed on the MS data set. Finally, Principal Component 
Analysis (PCA), orthogonal PLS-DA (OPLS-DA) and S-plot were performed. 
 
Supporting information  
The 1H, 13C NMR and HMBC and ESI-MS data of isolated compounds are available as 
Supporting Information. 
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Figure Legends 
 
Fig. 1 Scatter plot of the ion peaks of the L. theobromae extracts from different days A. 
in positive ionization and B. in negative ionization. 
 
Fig. 2 The 1H NMR data of L. theobromae extracts obtained from solid rice culture at 
three different incubation periods (solvent a is DMSO-d6; b is Chloroform-d). The 30-
day rice culture extract could only be fully dissolved in chloroform indicating the com-
pounds occurring in this extract are semi non-polar. 
 
Fig. 3 Anti-trypanosomal activity of L. theobromae fractions against T. b. brucei. LT: 
L. theobromae extract as positive control; LT2-LT19: L. theobromae fractions. 
 
Fig. 4 Above: The 1H NMR spectra of the 19 fractions; Below: The expansion of the 
1H NMR data of active anti-trypanosome fractions highlighting several unique chemical 
fingerprints found only in these fractions. 
 
Fig. 5 Chemometric analysis of L. theobromae fractions and anti-trypanosomal activity 
data correlation. A) The score scatter plot of OPLS-DA shows the samples were 
grouped based on their bioactivity. B) The permutation test result of the OPLS-DA 
model. C) The loading scatter plot of OPLS-DA shows the m/z values of active metabo-
lites D) The S-plot generated from the OPLS-DA model shows the end point com-
pounds that are the most predictive metabolites responsible for the bioactivity (high-
lighted in red). 
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Fig. 6 Chemical structures of unique metabolites (1-8) predicted from the S-plot and 
further secondary metabolites (6, 8-9) isolated from an active fraction of L. theobromae 
(Group 1).  
 
Fig. 7 The 1H-1H COSY correlation found in fraction LT-3 (Group 1) confirmed the 
substructure of desmethyl-lasiodiplodin. 
 
Fig. 8 The 1H-1H COSY spectrum of fraction LT-7 (Group 2) shows partial 
correlations of a) 6-Oxo-de-O-methyllasiodiplodin and b) preussomerin-C to confirm 
the presence of these metabolites determined from the dereplication of HR-LCMS data. 
 
Fig. 9 Three isolated compounds from L. theobromae labelled in the S-plot. R-(-)- 
mellein was in the middle of the plot, suggesting less anti-trypanosomal activity for this 
compound.  
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Table 1  Antitrypanosomal activity of L. theobromae extracts derived from V. pinnata 
in different types of media and incubation periods. MIC was only determined for the 
bioactive extracts 
  T. b. brucei T. b. brucei 
Sample 20 ȝg/ml 
MIC Average ± Std Dev 
(n=4)   
 
  % of viability  
LT-LC-7 112.3 Not tested 
LT-LC-15 106.3 Not tested 
LT-LC-30 126.0 Not tested 
LT-RC-7 103.9 Not tested 
LT-RC-15 94.3 Not tested 
LT-RC-30 1.4 25 ±  1.3 ȝg/ml 
Suramin Not tested 0.1 ± 0 ȝ0 
*LT- L. theobromae 
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Table 2 List of unique metabolites of L. theobromae active fractions obtained from S-
SORW³HQG-SRLQW´GDWDVKRZQRQ)LJXUHG3 SRVLWLYHPRGe; N=negative mode) 
 
Ionization 
Mode MS m/z 
Rt 
(min) 
Chemical 
Formula Name Group 
N 191.035 11.32 C10H8O4 6,8-Dihydroxy-3-methylisocoumarin(1) 2 
2 
2 
2 
2 
1 
1 
2 
2 
1 
1 
1 
N 291.124 13.17 C16H20O5 6-Oxo-de-O-methyllasiodiplodin (2) 
P 293.139 13.71 C16H20O5 6-Oxo-de-O-methyllasiodiplodin (2) 
N 395.077 13.60 C21H16O8 Preussomerin-C (3) 
N 363.051 14.61 C20H12O7 Preussomerin-H (4) 
N 333.077 17.61 C20H14O5 Palmarumycin CP17 (5) 
N 349.072 13.71 C20H14O6 Cladospirone B (6) 
P 321.17 19.14 C18H24O5 Phomopsin B (7) 
N 319.155 19.16 C18H24O5 Phomopsin B (7) 
N 277.144 21.79 C16H22O4 Desmethyl-lasiodiplodin (8) 
P 279.159 21.80 C16H22O4 Desmethyl-lasiodiplodin (8) 
N 555.296 21.79  Complex of 277.144 
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Table 3 Antitrypanosomal activity of isolated compounds obtained from L. theobromae 
fermented in solid rice culture for thirty days. 
Compound Antitrypanosomal activity 
(T. b. brucei) 
MIC Average ± Std Dev (n=4)  
 (ʅM) 
Cladospirone-B 6 
Desmethyl-lasiodiplodin 8 
R-(-)- mellein 9 
Suramin 
17.8 ± 0 
22.5 ± 1.50 
>100 ± 2.75 
0.1 ± 0 
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Fig. 2 
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Fig. 3 
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